Clinical Trials · NCT03523273
Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Michael Camilleri, MD
- Enrollment
- 136
- Start date
- Nov 2017
- Locations
- 1 site, United States
- Primary endpoint
- Gastric Emptying of Solids (T1/2)